Britain et al. [52] found that high expression levels of α2,6-sialyltransferase ST6Gal I that acts on complex N-glycans of EGFR correlates with EGF-triggered EGFR activation in pancreatic cancer cells [52,53]. Here, EGFR is linked to pancreatic neoplasm.